Stemson Therapeutics is a pre-clinical stage cell therapy company.
Stemson Therapeutics has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in July 2021.
Stemson Therapeutics's investors include AbbVie, DCVC Bio, Genoa Ventures, Fortunis Capital.
Stemson Therapeutics is headquartered in San Diego, United States.
Stemson Therapeutics is a pre-clinical stage cell therapy company.
Stemson Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stemson Therapeutics — Funding & Investors." VCBacked, July 15, 2021, https://www.vcbacked.co/company/stemson-therapeutics. Accessed September 20, 2026.
VCBacked. (2021). Stemson Therapeutics — Funding & Investors. Retrieved September 20, 2026, from https://www.vcbacked.co/company/stemson-therapeutics
{{cite web |title=Stemson Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/stemson-therapeutics |website=VCBacked |access-date=September 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated